These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
432 related items for PubMed ID: 26299240
1. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, Aykan AÇ, Çakal B, Bayram Z, Oğuz AE, Ertürk E, Yesin M, Gökdeniz T, Duran NE, Yıldız M, Esen AM. Am Heart J; 2015 Aug; 170(2):409-18. PubMed ID: 26299240 [Abstract] [Full Text] [Related]
2. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. Özkan M, Gündüz S, Biteker M, Astarcioglu MA, Çevik C, Kaynak E, Yıldız M, Oğuz E, Aykan AÇ, Ertürk E, Karavelioğlu Y, Gökdeniz T, Kaya H, Gürsoy OM, Çakal B, Karakoyun S, Duran N, Özdemir N. JACC Cardiovasc Imaging; 2013 Feb; 6(2):206-16. PubMed ID: 23489534 [Abstract] [Full Text] [Related]
3. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator. Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçık M, Oğuz AE, Gündüz S, Astarcioglu MA, Aykan AÇ, Bayram Z, Biteker M, Kaynak E, Kahveci G, Duran NE, Yıldız M. Circulation; 2013 Jul 30; 128(5):532-40. PubMed ID: 23812180 [Abstract] [Full Text] [Related]
4. Thrombolytic therapy for prosthetic valve thrombosis: short- and long-term results. Gupta D, Kothari SS, Bahl VK, Goswami KC, Talwar KK, Manchanda SC, Venugopal P. Am Heart J; 2000 Dec 30; 140(6):906-16. PubMed ID: 11099995 [Abstract] [Full Text] [Related]
5. Prolonged Infusions of Low-Dose Thrombolytics in Elderly Patients With Prosthetic Heart Valve Thrombosis. Gündüz S, Özkan M, Yesin M, Kalçık M, Gürsoy MO, Karakoyun S, Astarcıoğlu MA, Aykan AÇ, Gökdeniz T, Biteker M, Duran NE, Yıldız M. Clin Appl Thromb Hemost; 2017 Apr 30; 23(3):241-247. PubMed ID: 26447199 [Abstract] [Full Text] [Related]
6. Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events. Nagy A, Dénes M, Lengyel M. J Heart Valve Dis; 2009 May 30; 18(3):268-75. PubMed ID: 19557981 [Abstract] [Full Text] [Related]
7. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. Ozkan M, Kaymaz C, Kirma C, Sönmez K, Ozdemir N, Balkanay M, Yakut C, Deligönül U. J Am Coll Cardiol; 2000 Jun 30; 35(7):1881-9. PubMed ID: 10841239 [Abstract] [Full Text] [Related]
8. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis. Lengyel M, Vegh G, Vandor L. J Heart Valve Dis; 1999 Mar 30; 8(2):167-73. PubMed ID: 10224577 [Abstract] [Full Text] [Related]
9. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial. Özkan M, Kalçık M, Gürsoy MO, Öcal L, Griffini S, Karakoyun S, Yesin M, Gündüz S, Astarcıoğlu MA, Bayam E, Cerşit S, Aykan AÇ, Cugno M. J Cardiovasc Pharmacol Ther; 2016 Jul 30; 21(4):372-80. PubMed ID: 26657322 [Abstract] [Full Text] [Related]
10. Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis. Kathirvel D, Justin Paul G, Prathap Kumar G, Palanisamy G, Gnanavelu G, Ravishankar G, Swaminathan N, Venkatesan S. Indian Heart J; 2018 Jul 30; 70(4):506-510. PubMed ID: 30170645 [Abstract] [Full Text] [Related]
11. Successful thrombolysis of a subacute prosthetic valve thrombosis with modified ultra-slow thrombolytic therapy. Altay H, Kocabaş U, Yıldırımtürk Ö, Özkalaycı F, Sarıtaş B, Pehlivanoğlu S. Echocardiography; 2018 Aug 30; 35(8):1243-1244. PubMed ID: 29943853 [Abstract] [Full Text] [Related]
12. Thrombolysis or Surgery in Patients With Obstructive Mechanical Valve Thrombosis: The Multicenter HATTUSHA Study. Özkan M, Gündüz S, Güner A, Kalçık M, Gürsoy MO, Uygur B, Keleş N, Kaya H, Kılıçgedik A, Bayam E, Kalkan S, Astarcıoğlu MA, Karakoyun S, Yesin M, İnan D, Fedakar A, Sarıkaya S, Aksüt M, Onan B, Koçoğulları CU. J Am Coll Cardiol; 2022 Mar 15; 79(10):977-989. PubMed ID: 35272803 [Abstract] [Full Text] [Related]
13. Improvement of endothelial function early after thrombolytic therapy in patients with prosthetic heart valve thrombosis. Çakal B, Kalçık M, Güner A, Yesin M, Gürsoy MO, Gündüz S, Karakoyun S, Bayam E, Kalkan S, Özkan M. Turk Kardiyol Dern Ars; 2020 Sep 15; 48(6):566-575. PubMed ID: 32955025 [Abstract] [Full Text] [Related]
14. A Case Series of Obstructive Prosthetic Mitral Valve Thrombosis, Successfully Treated with Low-Dose, Slow Infusion Tissue-Type Plasminogen Activator. Ari H, Dogan A, Ceviker K, Aksoy F, Arslan A, Varol E. J Heart Valve Dis; 2015 May 15; 24(3):353-9. PubMed ID: 26901912 [Abstract] [Full Text] [Related]
15. Obstructive Thrombosis of Left-Sided Mechanical Heart Valves: Clinical Profile and Thrombolytic Therapy. Chandrakasu A, Jayachandran A, Gopinath Nayar P, Meyyappan C, Narayan G, Basha Abdul Bari A, Johnson Samuel P. J Heart Valve Dis; 2017 May 15; 26(3):344-348. PubMed ID: 29092121 [Abstract] [Full Text] [Related]
16. The leading role of thrombolysis in the management of prosthetic valve thrombosis. Gürsoy MO, Kalçık M, Yesin M, Karakoyun S, Özkan M. Indian Heart J; 2016 May 15; 68(2):205-6. PubMed ID: 27133340 [No Abstract] [Full Text] [Related]